Status: current, Defined. Date: 30-Jun 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2759621000168113 | Serenace 2 mg/mL oral liquid, drop | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2759631000168111 | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | has manufactured dose form | oral liquid | true | Inferred relationship | Some | ||
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Is a | Serenace | true | Inferred relationship | Some | ||
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Is a | haloperidol 2 mg/mL oral liquid, drop | true | Inferred relationship | Some | ||
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | has manufactured dose form | oral liquid solution | false | Inferred relationship | Some | ||
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | has unit of use | drop | true | Inferred relationship | Some | 2046805211 | |
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | has intended active ingredient | haloperidol | true | Inferred relationship | Some | 2046805210 | |
| Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | has Australian BoSS | haloperidol | true | Inferred relationship | Some | 2046805210 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Serenace 2 mg/mL oral liquid, 15 mL | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1219334177 |
| Serenace 2 mg/mL oral liquid, 500 mL | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1212245380 |
| Serenace 2 mg/mL oral liquid, 15 mL, bottle | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1822376735 |
| Serenace 2 mg/mL oral liquid, 500 mL, bottle | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1814996095 |
| Serenace 2 mg/mL oral liquid, 100 mL | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1 |
| Serenace 2 mg/mL oral liquid, 100 mL, bottle | has TPUU | True | Serenace (haloperidol 2 mg / 1 mL) oral liquid, 1 mL drop (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR